Epidemiology and clinical manifestations of Adamantiades-Behçet disease in Germany - Current pathogenetic concepts and therapeutic possibilities;Epidemiologie und klinik des morbus Adamantiades-Behçet in Deutschland - Aktuelle pathogenetische konzepte und therapeutische möglichkeiten

JDDG - Journal of the German Society of Dermatology

Volumn 4, Issue 1, 2006, Pages 49-66

  Altenburg, Andreas ^a,b   Papoutsis, Nestor ^a   Orawa, Helmut ^a   Martus, Peter ^a   Krause, Lothar ^a   Zouboulis, Christos C ^a,b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b DESSAU MEDICAL CENTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTIINFECTIVE AGENT; ASCORBIC ACID; AZATHIOPRINE; CALCINEURIN INHIBITOR; CHLORAMBUCIL; CHLORHEXIDINE; COLCHICINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTOKINE; DAPSONE; ETANERCEPT; GLYCEROL; HEAT SHOCK PROTEIN; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; LOCAL ANESTHETIC AGENT; MESALAZINE; PENTOXIFYLLINE; PREDNISOLONE; SALAZOSULFAPYRIDINE; TETRACYCLINE; THALIDOMIDE; TSUKUBAENOLIDE;

ADAMANTIADES BEHCET DISEASE; APHTHOUS STOMATITIS; ARTHRITIS; ARTHROPATHY; BACTERIAL INFECTION; BLINDNESS; BRAIN VASCULITIS; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL FEATURE; COLITIS; CONNECTIVE TISSUE DISEASE; DIAGNOSTIC TEST; DIFFERENTIAL DIAGNOSIS; DIGESTIVE SYSTEM ULCER; DRUG INDUCED DISEASE; DUODENITIS; ENCEPHALITIS; EPIDIDYMITIS; ERYTHEMA NODOSUM; ESOPHAGITIS; EYE DISEASE; GASTRITIS; GASTROINTESTINAL DISEASE; GENITAL ULCER; GERMANY; HEARING LOSS; HEMOPTYSIS; HISTOPATHOLOGY; HUMAN; MENINGOENCEPHALITIS; NEUROLOGIC DISEASE; NEUTROPHIL; OPTIC NERVE ATROPHY; OUTCOME ASSESSMENT; PAIN; PERIPHERAL NEUROPATHY; PRICK TEST; PROSTATITIS; PYRAMIDAL SIGN; RETINITIS; REVIEW; SKIN DEFECT; SKIN DISEASE; SKIN TEST; SYMPTOMATOLOGY; SYSTEMIC THERAPY; THROMBOPHLEBITIS; THROMBOSIS; UVEITIS; VASCULAR DISEASE; VIRUS INFECTION;

BEHCET SYNDROME; CROSS-SECTIONAL STUDIES; DIAGNOSIS, DIFFERENTIAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; RISK FACTORS; SKIN;

EID: 33645228217     PISSN: 16100379     EISSN: 16100387     Source Type: Journal    
DOI: 10.1111/j.1610-0387.2006.05841.x     Document Type: Review

References (15)

1. Zouboulis CC, Keitel W. A Historical review of early descriptions of Adamantiades-Behçet's Disease. J Invest Dermatol 2002; 119: 201-205.
2. Zouboulis CC. Morbus-Adamantiades-Behçet. Klinische und experimentelle Befunde von 53 Patienten aus dem Berliner Raum. Habilitationsschrift, Freie Universität Berlin, 1994.
3. Zouboulis CC. Epidemiology of Adamantiades-Behçet's Disease. In: Zierhut M, Ohno S: Immunology of Behçet's Disease. Lisse: Swets & Zeitlinger Publishers, 2003: 1-16.
4. Rogers RS 3rd. Recurrent aphthous stomatitis in the diagnosis of Behçet's Disease. Yonsei Med J 1997; 38: 370-379.
5. Krause L. Morbus Adamantiades-Behçet. Ophthalmologe 2005; 102: 329-334.
6. International Study Group for Behçet's disease. Criteria for diagnosis of Behçet's disease. Lancet. 1990; 335: 1078-1080.
7. Davatchi F, Shahram F, Akbarian M, Gharibdoost F, Nadji A, Chams C et al. Accuracy of existing diagnosis citeria for Behçet's disease. In: Wechsler B, Godeau P: Behçet's disease. International Congress Series 1037. Amsterdam London New York Tokyo: Excerpta Medica, 1993; 225-228.
8. Zouboulis CC, May T. Pathogenesis of Adamantiades-Behçet's disease. Med Microbiol Immunol 2003; 192: 149-155.
9. Zouboulis CC, Turnbull JR, Martus P. Univariate and multivariate analyses comparing demographic, genetic, clinical, and serological risk factors for severe Adamantiades-Behçet's Disease. In: Zouboulis ChC: Adamantiades-Behçet's Disease. London Amsterdam: Kluwer/Plenum, 2003; 123-126.
10. Imirzali N, Dursun A, Tastan B, Soysal Y, Yakicier MC. MEFV gene is a probable susceptibility gene for Behçet's disease. Scand J Rhematol 2005; 34: 56-58.
11. Zouboulis CC, Turnbull JR, Mühlradt PF. High seroprevalence of anti-Mycoplasma fermentans antibodies in patients with malignant aphthosis. J Invest Dermatol 2003; 121: 211-212.
12. Zouboulis CC. Adamantiades-Behçet's disease. In: Katsambas AD, Lotti TM: European Handbook of Dermatological Treatments. 2nd edition. Berlin Heidelberg: Springer, 2003; 16-26.
13. Sakane T, Mochizuki M, Inaba G, Masuda K. A phase II study of FK506 (tacrolimus) on refractory uveitis associated with Behcet's disease and allied conditions. Ryumachi 1995; 35: 802-813.
14. Sfikakis PP. Behçet's disease: a new target for anti-tumor necrosis factor treatment. Ann Rheum Dis 2002; 61: 51-53.
15. Melikoglu M, Fresko I, Mat C, Ozyazgan Y, Gogus F, Yurdakul S et al. Short-term trial of etanercept in Behçet's disease: a double blind, placebo controlled study. J Rheumatol 2005; 32: 98-105.